GM-XANTHO

Xantho Biotechnology Co., LTD · Phase 2 active Small molecule

At a glance

Generic name	GM-XANTHO
Also known as	Placebo
Sponsor	Xantho Biotechnology Co., LTD
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Study of GM-XANTHO in Pressure Ulcer Patients (PHASE2)
A Phase I/IIa Study to Investigate the GM-XANTHO in Healthy Volunteers and Atopic Dermatitis Patients (PHASE1, PHASE2)
A Study to Investigate the Efficacy and Safety Profile of GM-XANTHO [GM-XAN003] in Patients with Psoriasis (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

GM-XANTHO CI brief — competitive landscape report
GM-XANTHO updates RSS · CI watch RSS
Xantho Biotechnology Co., LTD portfolio CI